Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

NCT05539677

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +46 more
Locations: N.N. Petrov NMRC of Oncology, Oncoimmunology dep. Saint Petersburg, Russia

View Trial Details

Recruiting

Neoadjuvant Combination Immunotherapy for Stage III Melanoma

NCT03842943

Conditions: Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
Locations: University of Louisville Louisville, Kentucky, United States

View Trial Details

Recruiting

Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion

NCT03685890

Conditions: In-Transit Metastasis, Melanoma, Neoplasms, +10 more
Locations: Netherlands Cancer Institute Amsterdam, Netherlands

Erasmus MC Cancer Institute Groningen, Netherlands

Erasmus MC Cancer Institute Rotterdam, Netherlands

Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Recruiting

Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC

NCT06369181

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +19 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

NCT06265025

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +47 more
Locations: National Cancer Center Goyang-si, Gyeonggi-do, South Korea

Korea University Anam Hospital Seoul, South Korea

Hanyang University Seoul Hospital Seoul, South Korea

Severance Hospital, Yonsei University Health System Seoul, South Korea

View Trial Details

Recruiting

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

NCT05280314

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +14 more
Locations: Yale New Haven, Connecticut, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Massey Cancer Center Richmond, Virginia, United States

Melanoma Institute Australia The Uiniversity of Sydney, and Royal North Shore Hospital Sydney, New South Wales, Australia

View all 15 locations

View Trial Details

Recruiting

68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC

NCT06277180

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +13 more
Locations: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Recruiting

Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients

NCT06154668

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: CHU Grenoble Alpes Grenoble, France

View Trial Details

Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

NCT04282044

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +64 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Stanford University Stanford, California, United States

View Trial Details

Recruiting

Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations

NCT06229340

Conditions: Colonic Diseases, Colorectal Cancer Recurrent, Colorectal Neoplasms, +33 more
Locations: Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation Saint Petersburg, Russia

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions